Stoke Therapeutics, Inc. STOK Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s net income?
- Stoke Therapeutics, Inc. (STOK) reported net income of -$50M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s net income changed year-over-year?
- Stoke Therapeutics, Inc.'s net income decreased by 144.3% year-over-year, from $112.88M to -$50M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s net income?
- Over 4 years (2021 to 2025), Stoke Therapeutics, Inc.'s net income has grown at a -46.8% compound annual growth rate (CAGR), from -$85.81M to -$6.89M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.